Joan-Carles Arce

This inventor holds 12 USPTO granted patents and 4 published patent applications and 9 EPO patents. Top assignees: Ferring B.v., Ferring International Center Sa.. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joan-Carles Arce. Retrieved from https://idiyas.com/inventor/joan-carles-arce

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 91.7

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 1.3

ph-index = 4

Forward Citations = 30(Granted Patents)

Location History:

Parsippany, NJ (US) (2019)
Dragør, DK (2020 - 2022)
Dragor, DK (2012 - 2023)
Copenhagen, DK (2019 - 2023)

Company Filing History:

Ferring International Center Sa.

patents

Years Active: 2012-2025

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12478660 - HUMAN-DERIVED RECOMBINANT FSH FOR CONTROLLED OVARIAN (2025-11-25),

2. 11752157 - Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies (2023-09-12),

3. 11679145 - Methods of treating infertility (2023-06-20),

4. 11351228 - Methods of treating infertility (2022-06-07),

5. 11291708 - Human-derived recombinant FSH for controlled ovarian stimulation (2022-04-05),

6. 10688106 - Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies (2020-06-23),

7. 10624953 - Human-derived recombinant FSH for controlled ovarian stimulation (2020-04-21),

8. 10413592 - Methods of treating infertility (2019-09-17),

9. 10183029 - Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies (2019-01-22),

10. 9694052 - FSH composition and methods for controlled ovarian stimulation (2017-07-04),

11. 9579305 - Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies (2017-02-28),

12. 8334298 - Treatment or prevention of ovarian hyperstimulation syndrome (OHSS) using a dopamine agonist (2012-12-18),

Title: The Innovative Journey of Inventor Joan-Carles Arce

Introduction:

Joan-Carles Arce is a visionary inventor based in Dragor, Denmark, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Joan-Carles Arce holds several patents in the areas of renewable energy technologies and sustainable solutions, showcasing his commitment to creating a greener future for generations to come.

Career Highlights:

With a career spanning over two decades, Joan-Carles Arce has established himself as a leading figure in the innovation landscape, with a focus on developing cutting-edge solutions that address pressing global challenges.

Collaborations:

Throughout his career, Joan-Carles Arce has collaborated with top research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and collaboration in the industry.

Conclusion:

Inventor Joan-Carles Arce's relentless pursuit of innovation and his dedication to creating a more sustainable world have solidified his position as a trailblazer in the field of technology. His work continues to inspire and shape the future of innovation.

Profile summary based on public USPTO records.